Qipeng Xie

13PUBLICATIONS
13CO-AUTHORS
Medical biochemistry - lipidsCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 27, 2026
Integrating lipometabolic and adiposity indices to enhance risk stratification for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: clinical utility and interplay between triglyceride-glucose body mass index and low-density lipoprotein cholesterol.

|Jun 09, 2026
KRT14 Drives Basal Muscle-Invasive Bladder Cancer Progression and Lung Metastasis by Directly Binding to and Stabilizing IGF2BP1.

|May 12, 2026
Evaluation of the lipid accumulation product for MASLD risk stratification in type 2 diabetes: establishing sex-specific thresholds and clinical utility.

|Feb 18, 2026
CRTAC1 inhibits progression of lung adenocarcinoma by suppressing integrin/FAK signaling.

Yu Liu, Yuanyuan Chang, Haiying Li

|Aug 26, 2023
CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression.

Zihui Jin, Lingling Zhao, Yixin Chang

|Mar 07, 2023
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.

Shirui Huang, Jizhen Li, Shuang Wu

Pageof 3

Frequent Collaborators

4 joint publications

Haishan Huang

3 joint publications

Lingling Zhao

3 joint publications

Chuanshu Huang

2 joint publications

Ying Qu